California 2017-2018 Regular Session Status: In Committee

AB 1963 — Medi-Cal: reimbursement: opioid addiction treatment.

Last action — In committee: Held under submission.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Assembly
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2017-2018 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Existing law establishes the Medi-Cal program, which is administered by the State Department of Health Care Services and under which qualified low-income individuals receive health care services. The Medi-Cal program is, in part, governed and funded by federal Medicaid Program provisions. Existing law establishes the Drug Medi-Cal Treatment Program (Drug Medi-Cal) , under which the department is authorized to enter into contracts with each county, or enter into contracts directly with certified providers, for the provision of various alcohol and drug use treatment services, including substance use disorder services, narcotic treatment program services, naltrexone services, and outpatient drug-free services, to Medi-Cal beneficiaries. This bill would require the department to increase the Medi-Cal provider reimbursement rates, as specified, for medication-assisted treatments, buprenorphine/naloxone combination treatment, methadone treatment, and naltrexone treatment, provided by certified providers, for opioid addiction.

Bill Text

Action History

  1. In committee: Held under submission.

  2. In committee: Set, first hearing. Referred to APPR. suspense file.

  3. From committee: Do pass and re-refer to Com. on APPR. (Ayes 15. Noes 0.) (April 10). Re-referred to Com. on APPR.

  4. Coauthors revised.

  5. Re-referred to Com. on HEALTH.

  6. From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended.

  7. Referred to Com. on HEALTH.

  8. From printer. May be heard in committee March 2.

  9. Read first time. To print.

Sponsors

  • Dahle · Cosponsor
  • McCarty · Cosponsor
  • Waldron · Primary

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 2 co-sponsors · 119 not signed on

Sponsors (1)

  • Waldron

Co-sponsors (2)

  • Dahle
  • McCarty

Not signed on (119)

119 members have not signed on to this bill.

Show all 119 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does AB 1963 do?
Existing law establishes the Medi-Cal program, which is administered by the State Department of Health Care Services and under which qualified low-income individuals receive health care services. The Medi-Cal program is, in part, governed and funded by federal Medicaid Program provisions. Existing law establishes the Drug Medi-Cal Treatment Program (Drug Medi-Cal) , under which the department is authorized to enter into contracts with each county, or enter into contracts directly with certified providers, for the provision of various alcohol and drug use treatment services, including substance use disorder services, narcotic treatment program services, naltrexone services, and outpatient drug-free services, to Medi-Cal beneficiaries. This bill would require the department to increase the Medi-Cal provider reimbursement rates, as specified, for medication-assisted treatments, buprenorphine/naloxone combination treatment, methadone treatment, and naltrexone treatment, provided by certified providers, for opioid addiction.
Who sponsors AB 1963?
AB 1963 is sponsored by Dahle, McCarty, and Waldron.
What is the current status of AB 1963?
This bill died with 2017-2018 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track AB 1963?
Track AB 1963 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on AB 1963

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of AB 1963

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →